Bishop Michelle M, Beaumont Jennifer L, Hahn Elizabeth A, Cella David, Andrykowski Michael A, Brady Marianne J, Horowitz Mary M, Sobocinski Kathleen A, Rizzo J Douglas, Wingard John R
Department of Medicine, University of Florida College of Medicine, Gainesville, FL 32610-0277, USA.
J Clin Oncol. 2007 Apr 10;25(11):1403-11. doi: 10.1200/JCO.2006.07.5705.
Little is known about the long-term effects of cancer and hematopoietic stem-cell transplantation (HCT) on spouses or partners. The purpose of this study was to examine the health-related quality of life and post-traumatic growth (PTG) of spouses/partners compared with survivors and controls and to identify factors associated with those outcomes.
HCT survivor/partner pairs (n = 177), coupled continuously since HCT, were drawn from 40 North American transplantation centers. Married peer-nominated acquaintances (of survivors) served as controls (n = 133). Outcomes were measured a mean of 6.7 years after HCT (range, 1.9 to 19.4 years).
As expected, self-reported partner physical health was similar to controls and better than survivors (P < .001). However, partners reported more fatigue and cognitive dysfunction than controls (P < .001 for both), although less than survivors. Partners and survivors reported more depressive symptoms and sleep and sexual problems than controls (P < .001, P < .01, and P < .01, respectively). Odds of partner depression were nearly 3.5 times that of controls (P < .002). Depressed partners were less likely than depressed survivors to receive mental health treatment (P < .04). Partners reported less social support (P < .001), dyadic satisfaction (P < .05), and spiritual well-being (P < .05) and more loneliness (P < .05) than both survivors and controls. In contrast to survivors, partners reported little PTG (P < .001). Factors associated with partner outcomes included partner health problems, coping, female sex, social constraint, survivor depression, optimism, multiple life changes, and social support.
Spouses/partners experience similar emotional and greater social long-term costs of cancer and HCT than survivors without the potential compensatory benefits of PTG. Some of the factors associated with partner outcomes are amenable to intervention.
关于癌症和造血干细胞移植(HCT)对配偶或伴侣的长期影响,人们了解甚少。本研究的目的是将配偶/伴侣与幸存者及对照组进行比较,考察其与健康相关的生活质量和创伤后成长(PTG)情况,并确定与这些结果相关的因素。
从40个北美移植中心选取了自HCT后一直保持伴侣关系的HCT幸存者/伴侣对(n = 177)。已婚的由同龄人提名的(幸存者的)熟人作为对照组(n = 133)。在HCT后平均6.7年(范围为1.9至19.4年)对结果进行测量。
正如预期的那样,自我报告的伴侣身体健康状况与对照组相似,且优于幸存者(P <.001)。然而,伴侣报告的疲劳和认知功能障碍比对照组更多(两者P均 <.001),尽管比幸存者少。伴侣和幸存者报告的抑郁症状、睡眠问题和性问题比对照组更多(分别为P <.001、P <.01和P <.01)。伴侣患抑郁症的几率几乎是对照组的3.5倍(P <.002)。与抑郁的幸存者相比,抑郁的伴侣接受心理健康治疗的可能性更小(P <.04)。与幸存者和对照组相比,伴侣报告的社会支持更少(P <.001)、二元满意度更低(P <.05)、精神幸福感更低(P <.05)且孤独感更强(P <.05)。与幸存者不同,伴侣报告的PTG很少(P <.001)。与伴侣结果相关的因素包括伴侣的健康问题、应对方式、女性性别、社会限制、幸存者的抑郁、乐观情绪、多种生活变化以及社会支持。
与没有PTG潜在补偿益处的幸存者相比,配偶/伴侣经历了类似的情感方面的长期影响,以及更大的癌症和HCT带来的社会方面的长期代价。一些与伴侣结果相关的因素适合进行干预。